Submit the keyword or topic you are searching for

  1. Home
  2. Business
  3. Zydus Lifesciences shares in focus on USFDA approval for Deflazacort tablets
Business

Zydus Lifesciences shares in focus on USFDA approval for Deflazacort tablets

featured-image

Zydus Lifesciences Share Price | Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older..

My Protein Germany

Myprotein UK

Menkind UK

Top News

When commute gets pricier in Bengaluru

When commute gets pricier in city...

A homecoming and a reunion lead the storylines for this Knicks-Celtics showdown

Red Arrows, royals and street parties: What to look out for on VE Day at 80

Trump’s ‘big, beautiful’ budget plan delivers for America

Related Posts

post-thumbnail
Business

US rail freight still ahead of 2024 levels

post-thumbnail
Business

US stocks finish higher extending rally

post-thumbnail
Business

Warburg Pincus may double its returns from its six-year-old investment in SBI General Insurance

post-thumbnail
Business

Ripple (XRP) ETF Approval Odds Soar to 85%, But Experts Predict Ruvi AI (RUVI) Will Deliver 10,000% Growth and Hit $1 Soon

post-thumbnail
Business

Castlebar Capital Corp. Appoints New CEO

post-thumbnail
Business

Forum Energy Technologies, Inc. (FET) Q1 2025 Earnings Call Transcript

post-thumbnail
Business

Pebblebrook Hotel Trust: Deep Discount To NAV But Not Recommended

post-thumbnail
Business

MDA shares walloped by White House space cuts